发布于: | iPhone | 转发:1 | 回复:17 | 喜欢:0 |
Global biotechnology leader CSL Limited (ASX:CSL; USOTC:CSLLY) today announced a net profit after tax (NPAT) of $806 million for the six months ended 31 December 2016, up $87 million or 12% on a reported basis when compared to the prior comparable period (PCP). Reported earni...
奥克特珐玛是奥地利的
CSL是美国的,呵呵
话兰亘妎吧
他的市值是多少?谢谢!